calcimycin and Thyroid-Nodule

calcimycin has been researched along with Thyroid-Nodule* in 1 studies

Other Studies

1 other study(ies) available for calcimycin and Thyroid-Nodule

ArticleYear
Differential control of type-I iodothyronine deiodinase expression by the activation of the cyclic AMP and phosphoinositol signalling pathways in cultured human thyrocytes.
    Journal of molecular endocrinology, 1995, Volume: 14, Issue:2

    The effects of TSH and the activation of the cyclic AMP (cAMP) and Ca(2+)-phosphatidylinositol (Ca(2+)-PI) cascades on the activity and expression of the selenoenzyme thyroidal type-I iodothyronine deiodinase (ID-I) have been studied using human thyrocytes grown in primary culture. Stimulation of ID-I activity and expression was obtained with TSH and an analogue of cAMP, 8-bromo-cAMP. In the presence or absence of TSH, the addition of the phorbol ester, phorbol 12-myristate 13-acetate (PMA) together with the calcium ionophore A23187, caused a decrease in ID-I activity; a decrease in ID-I expression was also observed as assessed by cell labelling with [75Se]selenite. PMA alone had no effect on ID-I activity in the presence or absence of TSH. A23187 alone produced a small but significant reduction in ID-I activity, but only in TSH-stimulated cells. These data provide evidence that the expression of thyroidal ID-I is negatively regulated by the Ca(2+)-PI cascade, and positively regulated by the cAMP cascade.

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Calcimycin; Calcium; Carcinoma; Cells, Cultured; Cyclic AMP; Dimethyl Sulfoxide; Enzyme Induction; Graves Disease; Humans; Iodide Peroxidase; Microsomes, Liver; Phosphatidylinositols; Proteins; Selenoproteins; Signal Transduction; Sodium Selenite; Tetradecanoylphorbol Acetate; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin

1995